Literature DB >> 32460175

The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy.

Richard C Becker1, A Phillip Owens2, Sakthivel Sadayappan2.   

Abstract

Inflammation is often applied broadly to human disease. Despite its general familiarity, inflammation is highly complex. There are numerous injurious, immune and infectious determinants, functional elements and signaling pathways, ranging from genetic to epigenetic, environmental, racial, molecular and cellular that participate in disease onset and progression, phenotypic heterogeneity, and treatment selection and response. In addition, inflammation can be tissue and organ specific, adding a layer of complexity to achieving a detailed and translatable understanding of its role in health and disease. The following review takes a close look at inflammation in the context of two common heart diseases, hypertrophic cardiomyopathy and hypertensive cardiomyopathy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hypertensive cardiomyopathy; Hypertrophic cardiomyopathy; Neutrophil-derived extracellular traps; Tissue-specific inflammation; Von Willebrand factor

Mesh:

Substances:

Year:  2020        PMID: 32460175      PMCID: PMC7340095          DOI: 10.1016/j.thromres.2020.05.003

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  114 in total

1.  Activation of the human contact system on neutrophil extracellular traps.

Authors:  Sonja Oehmcke; Matthias Mörgelin; Heiko Herwald
Journal:  J Innate Immun       Date:  2009-02-20       Impact factor: 7.349

2.  Generation of blood vessel organoids from human pluripotent stem cells.

Authors:  Reiner A Wimmer; Alexandra Leopoldi; Martin Aichinger; Dontscho Kerjaschki; Josef M Penninger
Journal:  Nat Protoc       Date:  2019-09-25       Impact factor: 13.491

3.  Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.

Authors:  Alison Michels; Laura L Swystun; Jeffrey Mewburn; Silvia Albánez; David Lillicrap
Journal:  J Vis Exp       Date:  2017-08-14       Impact factor: 1.355

4.  Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.

Authors:  Dongmei He; Min Ye; Liwen Zhang; Binghu Jiang
Journal:  Heart Lung       Date:  2017-11-22       Impact factor: 2.210

Review 5.  Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.

Authors:  Barry J Maron; Martin S Maron; Bradley A Maron; Joseph Loscalzo
Journal:  J Am Coll Cardiol       Date:  2019-04-23       Impact factor: 24.094

6.  Relation of Blood Pressure in Childhood to Self-Reported Hypertension in Adulthood.

Authors:  Elaine M Urbina; Philip R Khoury; Lydia Bazzano; Trudy L Burns; Stephen Daniels; Terrence Dwyer; Tian Hu; David R Jacobs; Markus Juonala; Ronald Prineas; Olli Raitakari; Julia Steinberger; Alison Venn; Jessica G Woo; Alan Sinaiko
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

7.  Platelet-like particles dynamically stiffen fibrin matrices and improve wound healing outcomes.

Authors:  Seema Nandi; Erin P Sproul; Kimberly Nellenbach; Mary Erb; Lewis Gaffney; Donald O Freytes; Ashley C Brown
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

Review 8.  The double-edged role of neutrophil extracellular traps in inflammation.

Authors:  Maximilien Euler; Markus H Hoffmann
Journal:  Biochem Soc Trans       Date:  2019-12-20       Impact factor: 5.407

9.  Platelet interleukin-1alpha drives cerebrovascular inflammation.

Authors:  Peter Thornton; Barry W McColl; Andrew Greenhalgh; Adam Denes; Stuart M Allan; Nancy J Rothwell
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

Review 10.  Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders.

Authors:  Peter Szatmary; Wei Huang; David Criddle; Alexei Tepikin; Robert Sutton
Journal:  J Cell Mol Med       Date:  2018-08-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.